Paper41745765
Cross-Induction of Anti-Complexing Antibodies in Patients Treated with Botulinum Toxin Formulations Containing Complexing Proteins.
Srinoulprasert Y and 6 others. Toxins (Basel), 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Cross-Induction of Anti-Complexing Antibodies in Patients Treated with Botulinum Toxin Formulations Containing Complexing Proteins. Papers, record 41745765. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41745765
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Cross-Induction of Anti-Complexing Antibodies in Patients Treated with Botulinum Toxin Formulations Containing Complexing Proteins.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| N/A | Mahidol University | PubMed |
Source PubMed
References24
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 15201348 | Botulinum toxin in clinical practice. | J Neurol Neurosurg Psychiatry | 2004 | https://conductscience.org/library/papers/15201348 | PubMed |
| 2 | 21209727 | Complexing proteins in botulinum toxin type A drugs: a help or a hindrance? | Biologics | 2010 | https://conductscience.org/library/papers/21209727 | PubMed |
| 3 | 30013379 | Comparison of botulinum neurotoxin type A formulations in Asia. | Clin Cosmet Investig Dermatol | 2018 | https://conductscience.org/library/papers/30013379 | PubMed |
| 4 | 20418969 | Botulinum toxin. | Indian J Dermatol | 2010 | https://conductscience.org/library/papers/20418969 | PubMed |
| 5 | 36445847 | Botulinum toxin for cosmetic treatments in young adults: An evidence-based review and survey on current practice among aesthetic practitioners. | J Cosmet Dermatol | 2023 | https://conductscience.org/library/papers/36445847 | PubMed |
| 6 | 40729416 | Systematic Review and Meta-Analysis of Secondary Treatment Failure and Immunogenicity With Botulinum Neurotoxin A in Multiple Indications. | Eur J Neurol | 2025 | https://conductscience.org/library/papers/40729416 | PubMed |
| 7 | 36923693 | A Preclinical Study Comparing the Activity and Potency of OnabotulinumtoxinA and PrabotulinumtoxinA. | Clin Cosmet Investig Dermatol | 2023 | https://conductscience.org/library/papers/36923693 | PubMed |
| 8 | 32445175 | Association Between Secondary Botulinum Toxin A Treatment Failure in Cosmetic Indication and Anti-Complexing Protein Antibody Production. | Dermatol Ther (Heidelb) | 2020 | https://conductscience.org/library/papers/32445175 | PubMed |
| 9 | 40526262 | Diffusion Characteristics of LetibotulinumtoxinA, OnabotulinumtoxinA, and AbobotulinumtoxinA and its Impact on Muscle Relaxation: A Randomized Split-Face Clinical Trial. | Dermatol Ther (Heidelb) | 2025 | https://conductscience.org/library/papers/40526262 | PubMed |
| 10 | 24250334 | Efficacy of Onabotulinum Toxin A (Botox) versus Abobotulinum Toxin A (Dysport) Using a Conversion Factor (1 : 2.5) in Treatment of Primary Palmar Hyperhidrosis. | Dermatol Res Pract | 2013 | https://conductscience.org/library/papers/24250334 | PubMed |
| 11 | 30893162 | Efficacy and Safety of PrabotulinumtoxinA for the Treatment of Glabellar Lines in Adult Subjects: Results From 2 Identical Phase III Studies. | Dermatol Surg | 2019 | https://conductscience.org/library/papers/30893162 | PubMed |
| 12 | 35086302 | Immunogenicity of botulinum toxin. | Arch Plast Surg | 2022 | https://conductscience.org/library/papers/35086302 | PubMed |
| 13 | 38393178 | Complexing Protein-Free Botulinum Neurotoxin A Formulations: Implications of Excipients for Immunogenicity. | Toxins (Basel) | 2024 | https://conductscience.org/library/papers/38393178 | PubMed |
| 14 | 36136523 | Safety Profile and Lack of Immunogenicity of IncobotulinumtoxinA in Pediatric Spasticity and Sialorrhea: A Pooled Analysis. | Toxins (Basel) | 2022 | https://conductscience.org/library/papers/36136523 | PubMed |
| 15 | 30551641 | AbobotulinumtoxinA (Dysport®), OnabotulinumtoxinA (Botox®), and IncobotulinumtoxinA (Xeomin®) Neurotoxin Content and Potential Implications for Duration of Response in Patients. | Toxins (Basel) | 2018 | https://conductscience.org/library/papers/30551641 | PubMed |
| 16 | 28356439 | Botulinum Neurotoxins: Biology, Pharmacology, and Toxicology. | Pharmacol Rev | 2017 | https://conductscience.org/library/papers/28356439 | PubMed |
| 17 | 17928429 | Antibody detection and kinetics of antibody production during early stages of immunization with hepatitis B virus vaccine. | Clin Vaccine Immunol | 2007 | https://conductscience.org/library/papers/17928429 | PubMed |
| 18 | 35333944 | Toxicology and pharmacology of botulinum and tetanus neurotoxins: an update. | Arch Toxicol | 2022 | https://conductscience.org/library/papers/35333944 | PubMed |
| 19 | 40911274 | A Pilot Study of Differences in Antibody Responses of Intradermal and Intramuscular Injections of Botulinum Toxin Type A. | Dermatol Ther (Heidelb) | 2025 | https://conductscience.org/library/papers/40911274 | PubMed |
| 20 | 30681794 | IncobotulinumtoxinA: A Highly Purified and Precisely Manufactured Botulinum Neurotoxin Type A | J Drugs Dermatol | 2019 | https://conductscience.org/library/papers/30681794 | PubMed |
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ALB | 213 | PubTator's text mining | https://conductscience.org/library/genes/213 | NCBI Gene |
| CP | 1356 | PubTator's text mining | https://conductscience.org/library/genes/1356 | NCBI Gene |
| SNAP25 | 6616 | PubTator's text mining | https://conductscience.org/library/genes/6616 | NCBI Gene |
| TLR2 | 7097 | PubTator's text mining | https://conductscience.org/library/genes/7097 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Cited by
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41745765
GET https://conductscience.org/api/papers/v1/41745765/references?page=2